Magnetically-enhanced cell therapy and Philips' cancer biomarkers for personalised treatment
This article was originally published in Clinica
As of this edition, Clinica’s Patent Watch has changed its focus to medtech areas which are witnessing fast growth. These include regenerative medicine, drug delivery and emerging areas within personalised medicine such as molecular diagnostics. New patent applications published in May and June 2011 include tissue engineered vascular and orthopaedic grafts, drug-eluting gastrointestinal stents, ultrasound-triggered drug delivery, and diagnostic markers for cancer progression and prognosis.